Lobbying client
MARINUS PHARMACEUTICALS, INC.
Pharmacuetical development and commercializationi of therapeutic drugs
Filings
4
Filed by
1
Reported in-house
—
Reported by firms
$40,000
Filings
4 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
3rd Quarter - Termination (No Activity) 3rd Quarter 2010
|
MCKENNA, LONG & ALDRIDGE | — reported |
|
2nd Quarter - Report (No Activity) 2nd Quarter 2010
|
MCKENNA, LONG & ALDRIDGE | — reported |
|
1st Quarter - Amendment 1st Quarter 2010
|
MCKENNA, LONG & ALDRIDGE | $40,000 reported |
|
Registration 1st Quarter 2010
|
MCKENNA, LONG & ALDRIDGE | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| MCKENNA, LONG & ALDRIDGE | 3 | $40,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Defense | DEF | 2 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.